By Dr. Jason Mercer, Ph. D., RAC, Strategic Regulatory Innovator The world of cellular and gene therapy (CGT) is advancing rapidly, with new technologies offering transformative potential for patients facing serious and rare c...
Navigating the FDA’s Draft Guidance on Developing Cellular and Gene Therapy (CGT) Products
gET sOCIAL